Summary
- Current Price
- As of today, FDMT price is $13.98, down -2.31% in the most recent trading session on
- Current Price All-Time High
- FDMT price is currently -74.63% below its historical high of $55.11 set on
- Market Cap
- FDMT current market cap is $772M, up +89.15% over the past 365 days
- Revenue
- FDMT current annual revenue is $85.21M, up +230194.59% year-over-year
- Next Earnings
- The next earnings release for FDMT is on
Profile
| Metric | Value |
|---|---|
| Full Name | 4D Molecular Therapeutics, Inc. |
| Ticker | NASDAQ: FDMT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 4dmoleculartherapeutics.com |
| Employees | 227 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $13.98 | |
| Price, 1D Change | -2.31% | |
| $772M | ||
| - | ||
| - | ||
| 1.94 | ||
| $85.21M | ||
| Revenue, 1Y Change | +230,194.59% | |
| -$2.42 | ||
| EPS, 1Y Change | +18.90% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.42 | ||
| EPS Estimate | -$4.14 | N/A |
| EPS Est. Change | -70.99% | N/A |
| $85.21M | ||
| Revenue Estimate | $12.77M | N/A |
| Revenue Est. Change | -85.02% | N/A |
| Current Price | $13.98 | |
| Price Target | $28.00 | - |
| Price Tgt. Change | +100.29% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.92 | -$2.98 | -1.97% | |
| -$3.26 | -$2.42 | +25.78% | |
| -$4.14 | N/A | -70.99% | |
| -$4.09 | N/A | -69.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.38M | $37.00K | -97.33% | |
| $37.74M | $85.21M | +125.76% | |
| $12.77M | N/A | -85.02% | |
| $21.20M | N/A | -75.12% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $13.98 | |
| $10.41 | ||
| $13.28 | ||
| $11.05 | ||
| $13.59 | ||
| $0.26 | ||
| 1.94 | ||
| $0.98 | ||
| 50.21 | ||
| 56.29% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $85.21M | ||
| -$2.42 | ||
| $77.58M | ||
| 91.05% | ||
| -$159.55M | ||
| -187.24% | ||
| -$140.11M | ||
| -164.43% | ||
| -$151.92M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 9.39 | ||
| 9.39 | ||
| - | ||
| 3 | ||
| 5.82 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 8.39 | ||
| 1.89 | ||
| -2.38 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $505.66M | ||
| $402.66M | ||
| $566.71M | ||
| $413.13M | ||
| $61.05M | ||
| $43.99M | ||
| $21.41M | ||
| $5.59M | ||
| $11.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $225.32M | ||
| $237.13M | ||
| $7.63M | ||
| $0.00 | ||
| $7.63M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$109.08M | ||
| -$92.97M | ||
| $112.96M | ||
| $536.00K | ||
| -$109.62M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Cantor Fitzgerald | → | |
| B. Riley Securities | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Chardan Capital | → | |
| Barclays | ||
| Chardan Capital | → | |
| RBC Capital | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with FDMT
FAQ
- What is the ticker symbol for 4D Molecular Therapeutics, Inc.?
- The ticker symbol for 4D Molecular Therapeutics, Inc. is NASDAQ:FDMT
- Does 4D Molecular Therapeutics, Inc. pay dividends?
- No, 4D Molecular Therapeutics, Inc. does not pay dividends
- What sector is 4D Molecular Therapeutics, Inc. in?
- 4D Molecular Therapeutics, Inc. is in the Healthcare sector
- What industry is 4D Molecular Therapeutics, Inc. in?
- 4D Molecular Therapeutics, Inc. is in the Biotechnology industry
- What country is 4D Molecular Therapeutics, Inc. based in?
- 4D Molecular Therapeutics, Inc. is headquartered in United States
- When did 4D Molecular Therapeutics, Inc. go public?
- 4D Molecular Therapeutics, Inc. initial public offering (IPO) was on December 11, 2020
- Is 4D Molecular Therapeutics, Inc. in the S&P 500?
- No, 4D Molecular Therapeutics, Inc. is not included in the S&P 500 index
- Is 4D Molecular Therapeutics, Inc. in the NASDAQ 100?
- No, 4D Molecular Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is 4D Molecular Therapeutics, Inc. in the Dow Jones?
- No, 4D Molecular Therapeutics, Inc. is not included in the Dow Jones index
- When was 4D Molecular Therapeutics, Inc. last earnings report?
- 4D Molecular Therapeutics, Inc.'s most recent earnings report was on August 13, 2026
- When does 4D Molecular Therapeutics, Inc. report earnings?
- The next expected earnings date for 4D Molecular Therapeutics, Inc. is November 10, 2026
Data Sources & References
- FDMT Official Website www.4dmoleculartherapeutics.com
- FDMT Profile on Yahoo Finance finance.yahoo.com/quote/FDMT
- FDMT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fdmt